IBG-PHARMA Platform

(Principal Investigator: Prof. Dr. Mehmet İNAN)

IBG‑PHARMA Platform is an advanced technology center, operating under the İzmir Biomedicine and Genome Center (IBG), that offers services in the production of recombinant proteins, enzymes, and monoclonal antibodies, as well as the development of biotechnological drug candidates. The platform supports all stages of product development, from molecular discovery to preclinical evaluation.

IBG‑PHARMA is one of Turkey’s leading integrated technology platforms, fully covering the biotechnological product development pipeline from discovery through preclinical stages. We provide strong support to the industry with the following services and capabilities.